Réjean Lapointe

6PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 24, 2026
A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma.

Caroline Lambert, Rahima Jamal, Paméla Thébault

|Dec 23, 2022
Biomaterials for enhanced immunotherapy.

Nicholas Cunningham, Réjean Lapointe, Sophie Lerouge

|Apr 01, 2022
Spatially mapping the immune landscape of melanoma using imaging mass cytometry.

Dan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie

|Jun 17, 2021
CD40L-Stimulated B Lymphocytes Are Polarized toward APC Functions after Exposure to IL-4 and IL-21.

David Possamaï, Gabriel Pagé, Rébecca Panès

|Jul 24, 2020
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.

Joanne Langley, Elodie Pastural, Scott Halperin

|Mar 30, 2019
Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification.

Anne Monette, Derek Bergeron, Amira Ben Amor

Pageof 1

Frequent Collaborators

2 joint publications

LeeAnn Ramsay

1 joint publications

Joanne Langley

1 joint publications

Luis Martin

1 joint publications

Rébecca Panès